PEPDUCIN DESIGN AND USE
    14.
    发明申请
    PEPDUCIN DESIGN AND USE 审中-公开
    PEPDUCIN设计和使用

    公开(公告)号:US20140087993A1

    公开(公告)日:2014-03-27

    申请号:US14009479

    申请日:2012-04-09

    IPC分类号: C07K14/705

    摘要: Disclosed here is the rational design and use of potent and specific GPCR antagonist pepducins based on GPCR regions such as the third intracellular loop and adjacent regions.

    摘要翻译: 这里披露了基于GPCR区域(如第三细胞内环和相邻区域)的有效和特异性GPCR拮抗剂pepducin的合理设计和使用。

    G Protein Coupled Receptor Agonists and Antagonists and Methods of Use
    17.
    发明申请
    G Protein Coupled Receptor Agonists and Antagonists and Methods of Use 有权
    G蛋白偶联受体激动剂和拮抗剂及其使用方法

    公开(公告)号:US20080214451A1

    公开(公告)日:2008-09-04

    申请号:US11667042

    申请日:2005-11-04

    IPC分类号: A61K38/00 C07K14/00 A61P43/00

    摘要: The invention relates generally to G protein coupled receptors (GPCRs) and in particular to GPCR agonists and antagonists, use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with GPCRs, such as in treating conditions in which chemokine receptors play a role, e.g., sepsis, arthritis, inflammation and autoimmune diseases.

    摘要翻译: 本发明一般涉及G蛋白偶联受体(GPCR),特别是涉及GPCR激动剂和拮抗剂,这些化合物及其药物组合物的用途,例如用于治疗,调节和/或预防与GPCR有关的生理状态,例如 在治疗趋化因子受体起作用的病症中,例如败血症,关节炎,炎症和自身免疫性疾病。

    G protein coupled receptor agonists and antagonists and methods of use
    19.
    发明授权
    G protein coupled receptor agonists and antagonists and methods of use 有权
    G蛋白偶联受体激动剂和拮抗剂及其使用方法

    公开(公告)号:US08440627B2

    公开(公告)日:2013-05-14

    申请号:US11667042

    申请日:2005-11-04

    摘要: The invention relates generally to G protein coupled receptors (GPCRs) and in particular to GPCR agonists and antagonists, use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with GPCRs, such as in treating conditions in which chemokine receptors play a role, e.g., sepsis, arthritis, inflammation and autoimmune diseases.

    摘要翻译: 本发明一般涉及G蛋白偶联受体(GPCR),特别是涉及GPCR激动剂和拮抗剂,这些化合物及其药物组合物的用途,例如用于治疗,调节和/或预防与GPCR有关的生理状态,例如 在治疗趋化因子受体起作用的病症中,例如败血症,关节炎,炎症和自身免疫性疾病。